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Abstract
This study exatnilles factors in relapse to alcohol and drug dependence among health
professionals, seeking to identifY relationships between identified conditions and relapse.
The subjects are 100 health professionals, 84 male and 16 female, randomly selected
from a cohort of308, who provided data in a previous study taking place between 1995
and 1998 These subjects were broken into two groups, relapse vs. no relapse at 5 years
after participation in the original study, the post-marketing survey on tramadol (Knisely J,
Campbell E, Dawson K, Schnoll S, 2002). Archival data fi'om the previous study was
used. Chart review and analysis of archival data were the methods of data collection.
Data were analyzed using chi-square and one-way analysis of variance tests.
Presence of a comorbid personalitydisorder (Axis II) diagnosis was related to
relapse (X2 = 21.418, df= 1, p<.05), as was presence of a comorbid (Axis 1) psychiatric
diagnosis (secondary substance use diagnoses not included) (X 2 = 9.180, df= 1, p<.05).
The combination of a presence of both comorbid personality disorder and psychiatric
(axis 1) diagnoses were related to relapse (X2 = 23.645, df=l, p<.05).Level of treatment
comparing inpatient or residential and outpatient treatment did not provide a significant
correlation. The sample appeared to be too homogeneous on this variable for meaningful
companson.
Additional research, empirical and qualitative, is recommended to explore the
phenomenon of relapse among health professionals. Peer assistance programs are
encouraged to factor psychiatric disorders including personality disorders into evaluation
and treatment plans extending beyond initial treatment experience.
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Factors Related to Relapse Among Physicians in Recovery from
Substance Dependence Disorders

Substance use disorders include dependence upon alcohol and other drugs. These
disorders, in their more severe forms, are characterized by chronicity; relapse to active
use is a common part of the course of the disorder. Substance use disorders have been
compared to other chronic medical disorders such as arthritis, hypertension, asthma, and
diabetes (O'Brien & McLellan, 1996). Addicting drugs produce changes in brain
pathways that endure long after the person stops using the drug (O'Brien & McLellan,
1996). The adaptations made by the brain during drug use may be long term, or even
permanent (Powledge, 1999). As a result, medical, social, and occupational difficulties
that have developed during the course of addiction do not disappear when the person
discontinues use. Because substance use disorders are chronic, successful management,
rather than a cure, is the goal in treatment.
When relapse is conceptualized as a period of time during which a patient does
not make choices that contribute to effective disease management, then relapse to
chemical use appears to be similar to relapse in other chronic diseases. Relapse to
substance use following treatment is not uncommon. Approximately 40% to 60% of
patients receiving treatment for substance dependence remain abstinent for one year
following treatment. The remaining patients may be considered to be in some form of
relapse (McLellan, Lewis, O'Brien, & Kleber, 2000). Among patients suffering from
other chronic diseases, similar relapse rates can be observed. Studies have shown that
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fewer than 60% of adult patients with type 1 diabetes mellitus fully adhere to their
medication schedules, and fewer than 40% of patients with hypertension or asthma
adhere fully to their medication regimens. Similarly, fewer than 30% ofpatients with
adult-onset asthma, hypertension, or diabetes adhere to prescribed diet or behavioral
changes (McLellan, Lewis, O'Brien, & Kleber, 2000). The remaining 70% may be
considered in relapse in the sense that they are not effectively managing the disease.
It is interesting to note, however, that for patients with diabetes, hypertension, and

asthma, relapse following treatment is usually considered evidence ofthe success of the
treatment, and is indicative of the need to reinstitute successful disease management, and
to retain the patient in medical monitoring. In contrast, relapse to drug or alcohol use
following discharge from addiction treatment has been considered evidence oftreatment
failure (McLellan, Lewis,

O~Brien, &

Kleber, 2000). It is important that professionals

treating substance use disorders come to recognize relapse as a part of the process of
recovery from substance dependence, and that the public receive help to understand this
concept. It is equally imp0l1ant to learn to help patients manage this chronic illness more
effectively on a long-term basis.
Much attention has been paid to the role of stress in relapse. Marlatt's relapse
model holds that individuals utilize coping strategies successfully; however, there are
certain situations that may stress the individual's resources for coping. In this model
there would be times when the individual is faced with interpersonal high-risk situations,
negative emotional states, and positive emotional states (Marlatt, 1996). Stressors that
represent negative emotional states might range from dramatic or severe events, such as
loss of a loved one or a divorce, to chronic irritants of daily life such as [mandai worries
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or difficulties on the job. In animal models, both the initiation and reinstatement of
alcohol and other drug use (AOD use) are facilitated by exposure to stress. It is believed
that stress modifies the motivational and or reinforcing effects of AOD use by increasing
the activity ofthe dopaminergic brain systems that are involved in motivation and reward
(Brady & Sonne, 1999). Seratonln has also been suggested as having a role m the
relationship between AOD use and stress. Animals with low brain serotonin activity are
high consumers of alcohol, and when mjected with SSRI drugs, these laboratory anima]s
dramatically reduced their alcohol intake. Similar results have yet to be documented in
humans. Stress has been shown to bring about reinstatement of alcohol use in rats. In
fact, a single stressful experience, such as an electric shock induced resumption of drug
use m animals that had been previously taught to self-administer cocaine or heroin
(Brady & Sonne, 1999).
The reinstatement of previously learned behaviors m response to stress does not
generalize across all kinds of behaviors. For example, animals with a history oflever
pressing for food pellets, do not, when stressed, show remstatement of the previously
learned behavior. In other words, these animals under the stress of electric shock will not
"relapse" to pressmg a food pellet lever (Stewart, 2000). This difference between
animals with and without drug use history suggests, not only that stress is involved in
relapse to AOD use, but also that the presence of a history of AOD use may increase
vulnerability to stressful events. If this concept were to be generalized to humans, it
would mean that people with a history of AOD use might actually experience stressful
events with more subjective discomfort than a person without such a history, and be more
inclined to resort to previously learned, less productive, coping behaviors.

Factors in Relapse
Both acute and chronic stress appears to influence the use of alcohol in humans.
Crum and colleagues (1995) found that men in high strain jobs (high demands and low
control) generally had a higher risk of developing alcohol use disorders when compared
with men in low strainjobs (low demand and high control) (Crum, Muntaner, Eaton, &
Anthony, 1995). Researchers also have noted a high prevalence of stressful life events
(e.g. divorce or loss ofa loved one) in middle-aged women who developed alcohol
dependence later in life. These fmdings suggest that stress may have a causal
relationship with dependence on AOD.
Because alcohol mitigates emotional and physiological responses to stress, there
may be a tendency for those who experience this dampening effect most strongly to be
reinforced in alcohol use. Alcohol can result in reductions in anxiety and tension, as well
as in changes in heart rate or sweating. Women with a fumily history of alcoholism or
anxiety disorders exhibit a greater dampening effect of the stress response when using
alcohol than women without such a fumily history. This may well reinforce alcohol use
to a greater extent in such women, increasing vulnerability for alcohol dependence
(Sinha, Robinson, & O'Malley, 1998).
Additional evidence for the role of stress in relapse to AOD use can be found in
the research of Brown and colleagues (1990) who found that during a 3-month period
following treatment, patients who relapsed had experienced twice as much severe stress
before entering treatment than those patients who remained abstinent (Brown, McQuaid,
Patterson, Irwin, & Grant, 1990). This relationship between relapse post-treatment and
severe stress that occurred pre-treatment suggests a greater vulnerability to relapse in
response to stressful situations, if a person has suffered a high degree of stress and has

4
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used AOD to mitigate stress in the past.
There are several implications for treatment related to the effects of stress on
AOD use. It is clearly important to identify patients with a history either ofPTSD or
severe acute or chronic stress experiences, along with the use of AOD to mitigate the
effects of stress. IdentifYing these patients and teaching them to use and practice coping
skills for different stressful situations can be an important component of treatment.
Social support, problem solving skill training, and cognitive restructuring are widely used
strategies in treatment programs. Research is needed to assess the direct effects of such
strategies on relapse to AOD use (Stewart, 2000). Additionally, pharmacological agents
such as SSRIs may playa role in helping to minimize the risk of relapse due to stress. In
a study among patients with posttraumatic stress disorder, patients treated with the SSRI
fluoxetine (Prozac) showed improvement on a scale designed to measure stress resilience
(Stewart, 2000). Naltrexone, an opiate agonist, has also been effective in helping to
avoid relapse in detoxified alcoholics. This may be due partly to the effect of this opiate
agonist on the reward pathways in the brain, making it less likely that a stressful
experience will trigger a set of responses leading to relapse (Bouza, Angeles, Munoz, &
Amate,2004). It is also thought to reduce craving in patients recovering from alcohol
dependence.
Stress effects are usually considered in terms of negative events. Animal model
research is conducted, often using electric shock or some other noxious stimulus to create
a stressful situation. The Marlatt (1996) model identifies positive emotional states such
as celebrations, exposure to drug-related stimuli, and non-specific cravings as factors in
relapse. The notion that a particularly happy or positively exciting time could be a high
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relapse risk point may have merit. In some cases, relapse in response to a positive life
event could create a feeling of entitlement to use because one is on vacation or is in a
pleasant, non-demanding situation. Or it might reflect a response to a positive life change
such as the acquisition of a new, long sought after job that seems to offer solutions to
some oflife's problems. In either case, the phenomenon might be one of 'reduced
co gnitive vigilance' .
Malhotra, Malhotra, and Basu (1999) conducted a study in which they compared
beliefs about the causes of relapse to alcohol use; this was done between patients and the
patients' significant others in a population ofIndian alcoholics in recovery programs.
They found that the perceptions of cause of relapse were quite consistent across the
comparison. The cause of relapse most frequently reported both by significant others and
by patients was reduced cognitive vigilance. Three responses that fall within the category
of reduced cognitive vigilance were cited; these include 1. I've already taken a little, I
might as well go ahead; 2. I'm not really hooked on alcohol, I don't need to avoid it; and
3. One drink won't cause harm, I am doing so well. All three of these responses were
cited fi'equently by significant others as well as by patients and are good descriptions of
positive emotional state relapse. In fact, in this study, euphoric state relapse responses
were cited more frequently than were unpleasant mood state responses, with the least
common response being related to the unpleasant mood state of fear (Malhotra,Malhotra,
& Basu, 1999).

Craving or urge to use is closely related to the positive mood state factor of
relapse. Urge to drink refers to an emotional state characterized by the motivation to seek
and use AOD (Rohsenow & Monti, 1999). The term craving is sometimes used

Factors in Relapse
interchangeably with urge to drink; however, some writers use craving to mean a very
intense desire to use, yet others include a broad array of states of intensity of desires.
Negative emotional states, including interpersonal conflict, may precipitate coping with
AOD use, but craving implies the desire to use without these negative stimuli. Craving
has become a controversial topic in addiction treatment research literature. It has not
been clearly demonstrated in experimental studies and has been questioned by some
researchers and theorists (Tiffany & Conklin, 2000). The concept of drug craving
implies that cues related to prior use may cause a use response in a number of ways. One
model emphasizes drug withdrawal symptoms. In this model, the patient responds to
cues that create feelings related to withdrawal, and to avoid or to stop these feelings, the
patient will use.
A second model hypothesizes that drug-paired stimuli become conditioned
incentives that activate a central motivational state (Tiffany & Conklin, 2000). In other
words, the cue serves to create an autonomic reaction that is similar to the one caused by
actual use of the drug, bringing about a state of using before use occurs. This state then
brings about a relapse. Both models of craving imply use as a result of exposure to
stimuli or to cues related to past use.
According to social learning theory, relapse is associated with numerous learned
factors (Rohsenow & Monti, 1999). The urge to use in social learning theory is only one
factor, and is not sufficient to incur relapse. Social learning theory incorporates many
variables that contribute to the decision to use or not to use, including coping skills and
expectancies, which can be incorporated into treatment protocols.
A fourth concept describes craving as leading to drug use as an automatic

7
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information-processing phenomenon. This construct is based on the idea that many of
the thoughts and actions leading to use are automatic. This means that they can happen
without conscious thought or executive decision-making, similar to actions like driving a
car or buttoning one's clothing. The sets of thoughts and actions are so well learned that
they are automatic, and are regulated outside of conscious awareness (Tiffany & Conklin,
2000). This cognitive processing model replaces the concept of classically conditioned
responses either to withdrawal or to appetitive urges. The autonomic response model can
operate independently ofthe processes that control self'reports of craving (Tiffany &
Conklin, 2000). The treatment implications in this model would then focus not on
alleviation of craving, but on enhancing the likelihood that the drinker would be able to
avoid or counteract automatized use routines successfully. Cognitive-behavioral training
to recognize and interrupt these routines would be important to successful treatment.
Stimulus control strategies remain important, either in the form of behavioral therapy or
vis a vis Alcoholics Anonymous emphasis on changing exposure to people, places, and
things that are related to using drugs; however, a strategy to improve recognition of and
coping with cues that trigger automatic routines may be equally important.
A key factor in relapse research literature is coping responses. In particular,
Marlatt (1996) describes the factor as the ways in which an individual responds to high
risk situations. The outcome is determined in part by these coping responses, so the
coping responses are another group of antecedents to relapse, to the extent that the coping
responses are ineffective. The concept of self-efficacy is frequently identified as an
important part of an individual's ability to cope effectively with various types of
stressors. People with high self-efficacy see themselves as having the motivation and fhe
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ability to utilize strategies that will allow them to handle high-stress situations without
using AOD. These strategies can be behavioral, such as triggering a decision to leave a
situation, or can be cognitive, such as employing positive self-talk. The individual's
expectation of success in employing these strategies, or confidence in one's ability to
manage the stressful situation successfully is a measure of self-efficacy. A major goal of
cognitive-behavioral strategies for treating substance dependence or preventing relapse is
to enhance self-efficacy through the teaching of specific intervention skills. These skills
help the patient to identifY high-risk situations, eliminate myths and irrational beliefs,
anticipate the risk of relapse, and cope effectively with challenges to recovery. It is
important to help clients identifY their own risk situations as well as their own coping
strategies.
In the Relapse Prevention Model (Larimer,Palmer, & Marlatt, 1999) the client is
encouraged to become an objective observer ofhis/her own behavior, and to accept
responsibility for changing the behaviors that lead to relapse. In a large study of
alcoholics which included a 6-month follow-up study, the factors most related to
maintaining abstinence were self-efficacy expectancy and a long, previous time in
abstinence recovery. Both of these factors are related to the concept of self-efficacy
(Vielva, & Iraurgi, 2001). Similarly, in a study of 60 male problem drinkers, Allsop,
Saunders & Phillips (2000) found that the impact of self-efficacy, post treatment was
significant and consistent, making self-efficacy a major predictor of treatment outcome.
They recommended the use of a performance based relapse prevention model to erihance
recovery.
When attributions of relapse are examined, the concept of self-efficacy becomes

9
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even more important. Attribution theory is a way oflooking at how people arrive at
explanations for their own and

others~

behavior. People tend to use their attributions as a

form of self-presentation or impression management. Attribution theory holds that when
explaining negative actions, people are likely to attribute their own negative behavior to
external factors (outside their personal control), and to unstable factors (not likely to
occur again). On the other hand, when explaining the negative behavior of others,
according to attribution theory, people are likely to choose internal, stable, and global
factors. In studying attribution theory relative to the explanation of relapse by alcoholics,
it was hypothesized that there would be actor-observer differences; that is, that the
alcoholics might choose external and unstable causes to explain a relapse, but an observer
might choose internal and stable ones. The results ofthe study showed that there were
actor-observer differences when alcoholics rated their own relapses and the relapses of
others. However, the researchers found, that when explaining their own relapses,
respondents evoked attributions with an internal locus of causality, low external control,
and low personal control. The low external control and internal locus of causality ran
counter to expectations and hypothesis. In fact, these results showed that the respondents
attributed their own relapses to internal rather than external causes. They did rate

others~

relapses as even more internally based, but the locus of control was clearly internal
according to their self-ratings, which disproved the authors' hypothesis (Seneviratne &
Saunders,2000). This suggests that alcoholics tend to see relapse events as falling under
their own personal control.
Although it is very important to be able to see the self as having the ability to
cope successfully with stressful situations, including situations that previously may have
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contributed to drug using experiences, it is also important that the client develop a
realistic understanding ofthe potential effects ofthe drug. Many AOD users assign
positive efiects to the drug of choice, in spite ofthe fact that these effects generally have
not accompanied drug use. The expectation that a drug will help the individual cope with
a situation or set of feelings is a significant relapse factor (Larimer, Palmer, & Marlatt,
1999). Cognitive therapy may be a valuable tool to unpack that expectancy and to form a
better and more realistic set of expectations for results of drug use; it may also be an aid
to offset the tendency for outcome expectancy to add to risk for relapse. Identifying the
expectancy and the irrational basis for this expectation while in treatment may help the
client avoid the use ofthis mechanism to rationalize and justifY a decision to use alcohol
or other drugs.
In cognitive and social-cognitive models of relapse, factors, or situations that can
precipitate or contribute to relapse episodes can be identified. In the Relapse Prevention
Model (RP), these factors fall into two categories: immediate determinants and covert
antecedents (Larimer, Palmer, and Marlatt, 1999). The category of immediate
determinants includes such factors as high-risk situations, coping skill deficits, and
outcome expectancies. Factors such as lifestyle risks, urges, and cravings are classified
as covert antecedents.
According to the RP model, as a person maintains a behavior change like stopping
the use of alcohol, he or she becomes increasingly confident in his or her ability to
maintain the change. Certain situations, however, can pose a threat to the behavior
change, and can precipitate a relapse crisis. Several types of situations can be identified
as threats for relapse.

Factors in Relapse 12
1.

Negative emotional states are associated with the highest rates of
relapse (Marlatt, 1996). The category of negative emotional states
includes such states as anger, anxiety, depression, frustration, and
boredom. These states may be caused by intrapersonal perceptions of
situations or they may be environmental events such as feeling angry,
afraid, or sad about a possible layoff at work.

2.

Interpersonal high-risk situations, such as interpersonal conflict result
in negative emotions and are seen as relapse antecedents.

3.

Social pressure, including direct and indirect verbal and nonverbal
pressure to use, such as one might experience in spending time around
people who are using chemicals, may also precipitate relapse.

4.

Positive emotional states such as celebrations, exposure to drug related
stinmli or cues, and nonspecific cravings may trigger a relapse.

5.

The ways in which an individual responds to a high-risk situation help
determine the outcome. Coping responses, then, are another group of
antecedents, to the extent that some coping responses are ineffective,
and may lead to relapse.

6.

Outcome expectancies refer to the expectation of positive effects that
the user believes about the drug???? This effect can be seen readily in
situations where, in the midst of a high-risk situation, a user sees the
potential drug effects as a help in coping, such as a smoker's relapsing
to tobacco use during a period of anxiety over a life event. In such a
case, the outcome expectancy of the smoker, the expectation that the
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effect of the nlcotine will help him/her to manage the anxiety, becomes
a relapse factor.
7.

The Abstinence Violation Effect refers to the perception on the part of
the chemical user that the lapse to drug use is due to personal failure
and to internal traits that Call1ot be changed. These kinds of
perceptions lead to continued use, loss of control, and full-blown
relapse. Those who attribute the lapse to a deficit in coping with a
particular type of situation or to a particular coping skill deficit al'e less
likely to progress (Larimer,Palmer & Mailatt, 1999).

Comorbid Psychiatric Disorders
Given these varied relapse threat situations, it is likely that comoibid psychiatric
disorder traits or diagnoses may be important in the occurrence of relapse to active
chemical use. The risk factor of negative emotional states has received quite a bit of
attention in the research literature. Depression is a frequently occurring co-morbid
condition with substance use disorders. Because abstinence recovery (and relapse) in
severely dependent drug users is thought to be related to cognitive factors, one can easily
see how depression might be an important mediator. Depressed afiect can seriously affect
one"! s perceptions of self and the environment. There is little evidence to link depression
directly with relapse to substance use, but it has been implicated in relation to relapse in
conjunction with the subject's length of substance use history (Allsop, Saunders, &Phillips,
2000). (Strowig, 2000) Allsop, Saunders, & Phillips studied the relationship between
relapse risk and a number of factors including self-eflicacy at the conclusion of treatment,
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cognitive functioning, level of alcohol dependence, and level of alcohol consumption prior
to treatment. They observed a clear relationship between continued abstinence and selfefficacy, but depression was not directly related to relapse (Allsop, Saunders, &Phillips,
2000).
Similarly, depression was implicated in relapse status when the relationships
between the history of drug and alcohol use, treatment intake depression levels, and relapse
within a 6-monfh period following substance dependence treatment were studied. Here
depression was related to substance use history,but not directly to relapse following
treatment. Level and duration of substance use history emerged as the strongest predictors
of relapse (McMahon, Malow, & Loewinger, 1999). A history of substance use was,
however, found to be significantly related to levels of depression, yet across many studies,
the direct relationship between depression and relapse is statistically weak. Although
depression shows larger longitudinal correlation than many other variables, these
correlations are still small to moderate (Brewer, Catalano, Haggerty, Gainey, & Fleming,
1998).
Additionally, positive mood was significantly related to less cocaine use at follow
up, post treatment in a two-year follow up study on cocaine-dependent male veterans. In
this study, positive mood predicted less cocaine use at two of three follow-up assessment
points (6, 12, and 18 months), post-treatment (McKay, Merikle, Mulvaney, Weiss, &
Koppenhaver, 2001). Depressive symptoms during treatment have also been shown to be
related to relapse. In a study of alcohol relapse in cocaine users, high scores on the
Hamilton Rating scale were associated with greater urges to use, and subjects who
experienced higher levels of depressive symptoms during treatment were more likely to
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relapse to alcohol use following treatment (Brown, 1998).
Time of onset of depression may be an important part of the relationship between
depression and relapse. When Major Depressive Disorder (MDD) pre-exists treatment
and abstinence from substance dependence, it is a significant factor related to relapse.
ButMDD beginning in treatment or post treatment during abstinence is not shown to be a
factor (Hasin, Liu, Nunes, McCloud, Samet, & Endicott, 2002). This is an interesting
differentiation, because one might expect depression to be a normal part of recovery from
substance dependence, but a significant pre-existing depressive disorder, or the
development of a depressive disorder during abstinence recovery may be barriers to
successful recovery (Miller, 2002). In this connection, comorbidity of pre-existingMDD
can be seen as a major complicating factor in treatment and recovery and should be
treated differently from depressive symptoms that appear to be related to withdrawal and
early abstinence. Identification of depressive disorders that are premorbid relative to the
substance use disorder appears to be an important component of treatment. In fact, in
some cases, the premorbid depressive disorder may be found to be a primary or equally
bnportant diagnosis. When psychiatric disorders are studied in the context of treatment
for drug dependence, major depression consistently shows up as a predictor of more
substance use, and of poor treatment outcomes (Compton, CottIer, Jacobs, Ben-Abdallah,
& Spitznagel, 2003). Identifying and treating these depressive disorders in patients with

substance use disorders may be important to maintenance oflong-term recovery from
substance dependence.

Another significant factor contributing to risk of relapse is the presence of a
personality disorder. A personality disorder is an enduring pattern of inner experience
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and behavior that deviates markedly from the expectations of the individual's culture; it
is pervasive and inflexible, has an onset in adolescence or early adulthood, is stable over
time, and leads to distress or impairment (APA, 2000). In particular, researchers have
identified the presence of "cluster B" personality disorder diagnoses or traits as a
predictor of worse outcomes for substance use disorder patients. Cluster B personality
behaviors are described as dramatic, emotional, erratic, and/or self:destructive(Roozen,
2003). When substance dependent patients are evaluated for psychopathology, the
identification of personality disorders is cornmon. As many as 53 % of substance abuse
patients qualifY for at least one personality disorder diagnosis (Ross, Dermatis, Levounis,
& Galanter, 2003). The most frequently identified Axis II diagnoses in one study were

borderline personality disorder and antisocial personality disorder, both falling into
cluster B (Ross, Dermatis, Levounis, & Galanter, 2003). Skodol, Oldham and Gallaher
(1999) found that nearly 60% of patients in inpatient and outpatient substance use
disorder treatment had personality disorders, with borderline and antisocial disorders
being the most frequently identified. The presence of comorbid personality disorder has
also been shown to predict less successful outcomes in substance use disorder treatment;
this is particularly true of males with antisocial personality disorder (Compton, Cottler,
Jacobs, Ben-Abdallah, & Spitznagel, 2003).

Even with increased time in abstinence recovery, personality disorders persist.
Stiles (2002) studied groups of patients with 2 months through 1 year of sobriety; 1 to 5
years of sobriety and more than 5 years of sobriety. Patients across all three groups
showed either an axis I syndrome or an axis II trait or a disorder according to the Millon
Clinical Multiaxial Inventory. These studies point to the need to devote more attention
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to co-occurring psychopathology in treatment of substance dependent patients (Stiles,
2002).

In the Illinois study involving the programs at Rush Behavioral Health and
Parkside Hospitals, comorbid psychiatric disorders were more prevalent among relapsers
than among nonrelapsers. This was attributable mainly to a threefold higher percentage
ofrelapsers with narcissistic personality disorder (Angres, Talbott, & Bettinardi-Angres,
1998). Clearly, the presence of these personality disorders may affect outcome of
treatment for substance dependence disorders.

Physicians presenting for treatment for substance use disorders are presenting
more comorbid psychiatric pathology now than in the past, including more frequent
diagnosis of personality disorders. Angres, Delisi, Danesh,& Williams (2003) reviewed
retrospective data on 101 physicians treated for substance dependence at Rush-St. Luke's
Medical Center during 1985 to 1987; they compared these to physicians in the same
treatment program during 1995 to 1997. Co morbid psychiatric disorders were identified
in 45% of the 1980's cohort, but in the 1990's cohort, 60.3% of the treated physicians
had comorbid psychiatric diagnoses. Specifically, with regard to personality disorders,
25% of the 1980's cohort carried a personality disorder diagnosis, compared to 33% of
the 1990's cohort. The authors noted a predominance ofNarcissistic and Antisocial type
personality disorders (Angres,McGovem, Shaw, & Rawal, 2003).

Length of Use

Much attention has been paid to the issue of the relationship between the length of
time a substance-dependent patient has been using drugs and the patient's
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recovery/relapse. Age of first use has been studied as a predictor of the severity of drug
dependence or the subsequent treatment outcome. Age of onset of illicit chemical use
has been shown to be a strong predictor of a patient's drug use at age 20 (Labouvie,
Bates, & Pandina, 2000). In studying adolescent drug use progression, Yamaguchi and
Kandel (1984) found a strong association between a younger age offirst use and the
progession from marijuana to other illicit drug use.

Years oflifetime alcohol use has proved to be a significant predictor of relapse to
cocaine use within 6 months of residential treatment for cocaine dependence (McMahon,
Malow, & Loewinger, 1999). Grant, Stinson, and Harford (2001) found, through a
longitudinal study, that the odds of alcohol dependence decreased by 5 to 9% per year
with each decrease of one year of age at onset of drinklng. These authors found
significant associations between age of drinking onset and DSM-IV alcohol dependence
7 to 12 years later. A large longitudinal survey undertaken by the National Institute on
Alcohol Abuse and Alcoholism showed similar, but even more striking results. In this
study, the odds of dependence decreased by 14% with each increasing year of age at
onset of use, and the odds of abuse decreased by 8% for each increasing year of age at
onset (Grant & Dawson, 1997). Age of onset effects have been found in studies of
populations of opiate addicts, and may be similar to age of onset typology in alcoholism
(De, Matoo, & Basu, 2003). The time since first use as a continuous variable may have a
relationship to outcome after treatment.
Length of use has been viewed as a risk factor for treatment dropout and for
relapse. Age at onset is cited as one of the main risk factors for dropping out of treatment
or failing to progress to the next treatment level (Callaghan, 2003). However, in a large
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meta analysis of studies examining relapse to opiate use, length of use was found to be a
significant, but relatively weak, predictor of relapse (Brewer, Catalano, Haggerty,
Gainey, & Fleming, 1998).
In a research project conducted to explore factors in continued recovery vs.
relapse, age at frrst daily use emerged as a primary factor. The authors stated that the age
at onset of the drug user was a major factor in eventual relapse or recovery (Dekimpe,
Van de Gucht, Hanssens, & Powers, 1998). A study involving adolescents who met
criteria for alcohol dependence during the previous year showed similar results; age was
a variable that mediated risk of relapse (Dawson, Grant, Stinson, Chou, Huang, & Ruan,
2005). It is not clear whether or not length oruse can be differentiated from age at onset
in either of these two studies.
Physicians were compared with nurses in a substance dependence treatment
program. The hypothesis suggested that physicians had more opportunity to work a10ne
and avoid detection; therefore, their symptoms would be more severe than the nurse
population by the time they were admitted to treatment. The findings tended to support
this hypothesis, but length of use was only one aspect of the difference (Shaw,
McGovern, Angres, and Rawal, 2003). Length of use does not stand out as clearly
important as a relapse factor, but it certainly deserves attention in research.

Levelo/Treatment
Another variable that could be related to relapse is level of treatment received.
Physicians with a substance dependence diagnosis who become involved in formal
intervention and monitoring programs are sometimes referred for residential treatment
services. The rationale for residential treatment put forth by proponents of this modality
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is that it removes the patient (physician) from the environment in which substance use
has been occurring; it allows efforts toward abstinence to be consolidated; it provides a
setting that results in patients receiving more treatment; it provides more psychiatric and
medical care than outpatient settings; it provides more tangible and emotional support;
and gives a strong message to the patient that the disorder is severe and that recovery
activities are important (Finney & Hahn, 1996). Direct comparisons between treatment
modality outcomes are not readily available in the literature. Some researchers
specilically avoid such comparisons because of self selection and other factors that may
influence research results as confounds (Gossop, Marsden, Stewart, Edwards, Lehmann,
Wilson, & Segar, 1997). Additionally, in research on heroin dependent populations,
inpatient or residential treatment is sometimes compared with outpatient methadone
maintenance, which involves ongoing use of methadone. Many physician impairment or
monitoring programs would exclude ongoing methadone or suboxone use as an
acceptable treatment modality for a practicing physician.

Length oftreatment of patients treated for substance dependence disorders in
residential programs in England were compared with regard to patient outcomes. In this
study, outcomes for patients who participated in residential programs of2 to 5 weeks, 6
to 12 weeks, and 13 to 52 weeks were compared. The average time was 15 days in
inpatient treatment; 42 days in short-term residential treatment and 70 days in long-term
residential treatment. This study found a strong relationship between duration of
treatment and outcome. Patients who spent more time in residential treatment had better
outcomes (Gossop,Marsden, Sewart, & Rolfe, 1999). A major finding in the Washington
State Treatment Outcome Pilot Prospective Study was that patients receiving Full
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Continuum (FC) care (residential treatment) prior to outpatient treatment showed greater
improvement in psychiatric severity and in legal status from baseline to 9 months than
those receiving outpatient treatment only. The study also found that receiving FC care
appeared to be more effective for patients with higher alcohol and drug severity at intake
(French, Salome, Krupski, McKay, Donovan, McLellan, & Durell, 2000).
Angres, Talbott, & Bettinardi-Angres describe the treatment of health care
professionals, including physicians, as including the need for a strong peer-group
influence in treatment. Often, longer-phase treatment is indicated for the health care
professional with a substance dependence diagnosis. These authors describe a four-phase
treatment process; this includes one month of residential rehabilitation, residence in an
independent living setting with recovering peers, a second month of day hospital
attendance, and two months of mirror-image placement therapy. The mirror-image
placement therapy consists ofwoiking in some area of substance abuse treatment while
remaining in the independent, semi-structured living situation. This might involve
helping to collect urine toxicology samples fi'om residents, or orienting newer residents
(Angres, Talbott, & Bettinardi-Angres, 1998).

There is evidence that length of treatment is a factor in abstinence vs. continued
drug use. Treatment length and completion are seen as consistently and negatively
related to continued use whether the associations are measured concurrently or
10ngitudinally, indicating that subjects who remain in treatment longer and complete
treatment are less likely to continue to use chemicals than those who leave treatment
earlier, or who do not complete treatment (Brewer et aI, 1998). When cocaine dependent
patients were studied, it was clear that patients with more severe problems were likely to
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enter long-term residential treatment programs; lower levels of drug use at follow up
were reported by those who were treated for 90 days or longer (Simpson, Joe, Fletcher,
Hubbard, & Anglin, 1999). These studies indicate that longer periods of treatment affect
treatment outcomes favorably.

Other studies indicate a lack of support for residential treatment. Intensity of
treatment has been shown, in some cases, to be less important than rapid entry into
treatment (ear1y intervention), and length or duration of treatment (Moos & Moos, 2003).
In this case, duration, rather than intensity, was found to be important to long-term
outcome. Similarly, in a study of the effectiveness of the ''Minnesota Moder" approach
in the treatment of adolescent drug abusers, completion of treatment was a predictor of
favorable outcome (measured by abstinence during the 12 months following treatment),
but there were no outcome differences between subjects receiving residential vs.
outpatient treatment (Winters, Stinchfield, Opland,Weller, & Latimer, 2000).

Family History of SUD
The role of genetics in alcoholism and drug addiction has ~been well-established.

It has been estimated that about 40% ofthe risk for alcoholism is related to genetic
factors (Heath, 1995). A number of studies have contributed to the body of information
supporting a genetic factor, including studies on twins and on family systems. Twin
studies have shown that there is a 50 to 200% greater chance for identical twins to
develop alcoholism than for non identical twins (Heath, 1995). Alcoholism appears to be
passed on within family lines, and individuals with a family history of alcoholism are at
increased risk for developing alcoholism than are individuals without such a family
history. Sons of alcoholics are 4 to 9 times more likely to become alcoholic than are the
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sons of nonalcoholics (Heath, 1995). Sons of alcoholics who are adopted by
nonalcoholic families early in life are still more than three times likely to become
alcoholic than are adopted sons on nonalcoholic parents (Froehlich, Zink, Li, & Christian,
2000). Twin studies have been a strong indicator of genetic transmission of risk for
alcohol dependence.
The heritability of specific hormonal responses to alcohol has been studied, in an
effort to identifY mechanisms by which risk for alcohol dependence might be transmitted
from one generation to the next; it was also an attempt to identify biomarkers for people
at high risk for alcohol dependence. This research has shown that some hormonal
response patterns are very much linked to genetic transmission, as indicated through
studies involving monozygotic and dizygotic twins (Froehlich, Zink, Li & Christian,
2000). Because genetics appear to be related to the risk of developing substance use
disorders, it may also be related to risk of relapse to substance use among recovering
addicts.
A recent study conducted in India utilized the Family Interview for Genetic
Studies to collect data from family members of opioid-dependent men. The authors
found a high correlation between opioid-dependent men and their fIrst-degree relatives,
including opioid-dependent siblings and alcohol-dependent fathers (prasant, Mattoo, &
Basu, 2006). These findings are of interest because they demonstrate evidence of genetic
transmission of risk between an alcohol dependent parent and an opioid dependent son.
They also indicate that evidence continues to be compiled for the genetic transmission of
risk for substance use disorders. In China, a study seeking genetic markers with a
longitudinal approach yielded similar findings. In that study, a particular genetic allele
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was identified as a possible marker through a four-year process of assessment and
reassessment of aboriginal people (Cheng, Gau, Chen, Chen-Chang, & Terng-Chang,
2004).
The risk of relapse among recovering physicians with regard to family history of
substance use disorder was studied in a cohort of physicians recovering from substance
dependence disorders inWashlngton. In that study, the presence of a family history was
found to be a significant factor for risk of relapse to substance use. About 73% of the
subjects (case and control combined) reported a family history; this is in line with the
hypothesis that genetics are an important factor in the development of substance use
disorders. When relapse risk was computed, a family history of substance use disorder
was found to be a significant risk factor for relapse. In fact, the authors noted that the
presence of a family history approxilnately doubled the likelihood of relapse to alcohol
and drug use (P<.001) (Domino, Hornbein, Pollisar, Renner, Ginger, Johnson, A1berti, &
Hankes, 2005).

Eating Disorder Symptoms
The co morbidity of eating disorders and substance abuse has received attention in
recent years. The reports about the relationship between these disorders have been
mixed. A meta-analysis carried out in 1994 indicates that there is some relationship,but
there was a lack of distinction in some studies between substance use and abuse. In
general, it appeared that there was a greater relationship between bulimia and substance
abuse than between anorexia or restricting food and substance abuse (Holderness,
Brooks-Gunn, & WalTen, 1994). Because eating disorders appear to be comorbid with a
number of disorders, it is difficult to sort out specific comorbidity with substance abuse
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in the absence of other disorders. A marginal relationship was identified, however,
between binge eating and heavy alcohol use by Piran and Robinson (2006).
Some research has indicated the possibility that eating disorders and substance
dependence disorders may share some common factors in terms of psychological issues
as well as in terms of brain chemistry. These authors reviewed a number of studies that
provided evidence of co-occurrence/comorbidity of substance use disorders and eating
disorders. They point out that co-occurrence refers to the fact that disorders occur in the
same individual during the same period, while comorbidity suggests that there are factors
in one disorder influencing the development ofthe other disorder. They suggest the use
of general criteria in establishing comorbidity between disorders, indicating that this term
be used only when the incidence of the combined disorders appears to be greater than
base rates for either disorder in the population (Grilo, Sinha, & O'Malley, 2002).
Curtis, Jason, Olson, & Ferrari (2005) studied women in substance abuse recovery
homes and found that women with substance-related disorders are likely to suffer from
eating disorders, but they did not attempt to identifY a relationship between the presence
of an eating disorder and the outcome of a substance abuse recovery program. It does
appear, however, that individuals with eating disorders are more likely to have a
substance use disorder, and that people with substance use disorders are more likely to
have eating disorders (Curtis, Jason, Olson, & Ferrari 2005). The relationship between
the two types of disorders is, however, apparently not well-understood.
Eating disorders appear to be found commonly in college-age women.
Among female college students with eating disorder symptoms, purging appears to be
related to more frequent use of alcohol, as well as to more negative consequences from
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alcohol use. On one measure, these authors asked students who purged and students who
did not purge questions about drinking experiences. Respondents with purging behavior
answered affIrmatively at a rate of 84% compared to a 37.5% rate of afflrmation from
non purging students; the measure involved a question about doing something one later
regretted. Responses included the following: 73% to 12.5% on having unprotected sex,
42% to 12.5% on physical injury, and 42% to 25% on blackout symptoms (Anderson,
Martens, & Cimini, 2005). These data suggest a relationship not only between purging
and increased drinking, but also between purging and problem drinking symptoms.
lncreases in negative consequences from drinking experiences have also been reported
among college students without accompanying information indicating significantly
increased amounts of drmking. Dunn, Larimer, & Neighbors (2001) used an eating
disorder diagnostic scale along with assessments of drinking experience consequences to
identifY the relationship between eating disorder symptoms and problem drinking. They
found that students with eating disorder symptoms did not report drinking more, but did
report significantly more severe consequences to drinking experiences. These authors
also noted that students with eating disorder symptoms also reported more illicit drug use
experiences than did controls (Dunn, Larimer, & Neighbors, 2001).

History of Abuse
When risk factors for relapse are identified, history of childhood abuse of some
kind arises as a possible factor. Some substance abuse treatment programs report high
rates of reported childhood abuse among their clients. Much ofthe data available on this
topic has to do with sexual abuse history, and most ofthat data involves female clients.
The prevalence of this relationship between abuse history and female substance abuse
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clients:in treatment has been estImated to be as high as 48% to 64%. One program
indicated that 61 % offemale clients reported a history of sexual abuse, compared to 18%
of male clients (Burgdorf, Chen, Walker,Porowski, & Herrell, 2004). A recent study
reported that up to 80% of women seeking treatment for substance abuse have a history
of sexual abuse or trauma (Bien, Cohen, Miele, Caren, & Capstick, 2004). This
incidence of reported sexual abuse history among patients in substance abuse treatment
facilities suggests that a relationship exists between sexual abuse history and substance
abuse/dependence. However, the nature of that relationship is not clear. Sexual abuse
history does not appear to predIct completion oftreatment or recovery at follow up.
Neither is the nature ofthe relationship between these two entities clear. The identity of
the abuser (father, sibling, uncle) for many women seems to be an important variable.
Because history of sexual abuse often occurred in the context of alcoholic or actively
addicted parents, the family history of substance abuse disorder also may have an effect.
One disturbing discovery in this research is that higher percentages of women who were
sexually abused by their fathers are reported to have had plans or had taken actions
toward suicide, compared to women without such abuse histories (Burgdorf, Chen,
Walker, Porowski, & Herren, 2004). The connection between sexual abuse history and
substance abuse is complex.
When outcome measures for substance abuse treatment, such as relapse at a given
point in time, or completion of treatment are studied with respect to abuse history, it
seems clear that many measures of psychopathology are significantly related to childhood
abuse, but the outcome measures do not appear to be related in many cases (Gehrenbeck~
Shim, 1998). Individuals who suffer from the effects of childhood sexual or physical
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abuse seem to carry many psychological sequelae, but the effects of this history on
substance abuse treatment outcome, specifically on relapse, are not clear. A specific
review of outcomes of substance abuse treatment for clients with a history of abuse
compared to clients without such a history indicated that clients who have a history of
abuse appear to have more co-occurring psychiatric issues when in treatment, but the
history of abuse did not predict failure to complete treatment, nor the status of clients at
follow up one year after treatment (Pirard,Estee, Kang, Angarita, & Gastfriend, 2005).
Research data on childhood abuse is less available about males, possibly because
the subject of sexual abuse of males is even more taboo than this abuse of females (Relf,
2006). One study reviewed such data in order to ascertain effects on sexual behavior

with regard to HIV status, involving men who had a history of sexual abuse. Men with a
history of sexual abuse were found to be much more liable to have problems with alcohol
and drug use, and were more liable to have been hospitalized for alcohol or drug
problems (Relf, 2006). Indeed, when data on boys and men are sought and compared to
that of women on the topic of history of sexual abuse, substance abuse appears to be a
major correlate for men; however, it is among many different effects for women,
lncludlng affective and anxiety disorders in addition to alcohol abuse. For men,
substance abuse appeared to be the main effect (Finkelhor, 1990).
There appears to be a link between abuse history and trauma symptoms including
PTSD; this has also been studied in relation to substance abuse treatment. Again, the
connection appears but the effects are 1ess clearly identifiable. Women with self-reported
physical or sexual abuse histories score higher on substance use screening tests. These
women also appear to have more diagnosed substance problems in adulthood, even when
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the abuse occurred ill childhood or adolescence, and there has been no exposure to
trauma since that time (Stewart, 1996).
Living Arrangements
The question of the effect of one's living arrangements on substance abuse
disorder and on relapse is an illterestillg one. Much ofthe information ill the literature on
this topic is phrased around the cultural concept of marriage, and, as such, is likely
referrillg to heterosexual marriage. This is unfortunate,because living with a significant
other can be a factor in relapse or stability outside of the narrowly defined construct of
heterosexual marriage. However, examination ofthis data is important. In reviewing the
literature on this topic, one quickly moves from the notion that stable relationships
provide protective effects ill terms of relapse to substance use tor illdividuals ill
abstinence recovery.
Recent studies on gender differences ill substance abuse relapse have shown that
for men, marriage can be a protective factor; tor women, however, this status can act as
an additional risk factor. In this study, marriage was protective for men up to 15 months
post-treatment, but was a contributory factor to relapse in women at 3 months, posttreatment (Walitzer and Dearillg, 2006). These authors also cited a study mdicatillg that
men maybe more likely to relapse before a 3 month post-treatment follow up when
livillg alone, than women living alone (Walitzer & Dearillg, 2006).
There are also indications that, ill general, marriage is predictive of less chance of
relapse followillg treatment. In an analysis based on data from the 2001-02 National
Epidemiologic Survey on Alcohol and Related Conditions (NESARC), being married
was associated positively not only with the odds ofbeing either in abstillence recovery or
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m a form of non-abstinence recovery at follow up, but was also associated positively with
better outcomes (Dawson, Grant, Stmson, Chou, Huang, & Ruan, 2005).

Other Compulsive Behavior
The notion of compulsive behaviors interacting with treatment for substance
dependence has not been extensively explored. Compulsive gambling is one area of
compulsive behavior that has attracted attention with respect to its comorbidity with
substance dependence and the interaction of the two disorders. There is recognition of
the likelihood of comorbid occurrence of substance abuse and compulsive gambling, and
of the additional difficulty that is presented in recovery because of the interaction of the
two. Substance abusing compUlsive gamblers are thought to be harder to treat (Nathan,
2003), but the effects on recovery from compulsive gambling are not quantified.
When a population of compulsive gamblers in a recovery program was followed
for a year, substance abuse did not emerge as a significant factor in relapse, but lifetime
prevalence of a1cohol dependence in the population was high, at about 77% (Hodgms &
el-Guebaly, 2004). This finding suggests some connection between the two disorders.
Another recent study of adolescents who were involved in compulsive gambling
indicated that substance abuse was a predictor of problems with gambling (Hardoon,
Gupta, & Derevensky, 2004). Thus there is evidence of a relationship between the
disorders, but not that they are more than CO-occuITmg. Evidence of an effect on
addiction recovery by compulsive gambling has not been widely identified.
Kausch (2003) explored the patterns of substance abuse and compulsive
ganiblmg, and identified a number of impulsive behaviors m which gamblers tend to
engage. These mcIude compulsive shoppmg, compulsive spendmg, and compulsive
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sexual behaviors. This study identified the pattern indicating that substance abuse makes
all ofthese behaviors more likely, and that substance abuse interacts with the ,other
compulsive behaviors, complicating the recovery picture (Kausch, 2003). One can easily
see how these behaviors may interact to produce complications in substance abuse
recovery or in recovery from other compulsive behaviors.
Compulsive sexuality is characterized by high risk behavior. Review of case
studies of sexually compulsive women suggest a relationship between alcohol and drug
use and sexual acting out; one woman described feeling that when she drank, she knew
that she would likely end the evening by having sex with someone (Turner-Shults, 2002).
In studies of sexually compulsive men, drinking before compulsive sexual experiences is
also well-documented, suggesting that substance abuse, if not dependence, is commonly a
co-occurring disorder with sexual compulsivity among gay men (Relf, 2001).

Use o/Tobacco
The use of tobacco can be considered a co-occurring substance dependence
disorder along with alcohol or drug dependence. Traditionally, tobacco smokers
involved in 12-step recovery from alcohol and other drugs have tended to avoid the task
of stopping tobacco use during early recovery, with the thought that one addiction
recovery at a time is enough. In recent years, awareness has grown that tobacco use
involves addiction to nicotine, and there has been more interest in addressing smoking as
a co-occurring dependence. To study the effects of nicotine deprivation on people who
are in treatment for alcohol dependence, a group of researchers identified 40 patients in a
treatment program for alcohol dependence, and used rating instruments to help the
patients identify the effects of nicotine deprivation on the urge to drink, or the craving for
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alcohol. The researchers found that acute nicotine deprivation had a great effect on the
urge to smoke, but did not affect the urge to drink (Cooney, Cooney,Pilkey, Kranzler,&
Oncken, 2002). Based on therr fmdings, the authors recommended that individuals in
recovery from alcohol dependence can be encouraged to discontinue smoking during
treatment.
In fact, there is evidence that stopping or reducing tobacco use during recovery
from alcohol use disorders may enhance recovery. Project Match yielded data on
cigarette consumption and drinking outcomes (Friend & Pagano, 2005). Data from
Project Match was evaluated by dividing smokers into three groups according to whether
or not their smoking was unchanged, had increased, or had decreased from the beginning
of the study to a follow up point at 15 months. These data show that the smokers whose
cigarette consumption decreased were less likely to suffer a relapse to alcohol use than
smokers whose smoking behavior increased or stayed the same (Friend & Pagano, 2005).
These findings suggest that reducing tobacco use may have a positive effect on recovery
from alcohol dependence.
Similarly, the authors who published the Tramadol Post";Marketing Survey
examined physician data on smoking as part of follow up data analysis. They found a
correlation between past smoking and current smoking and relapse, comparing this data
with non-smokers and rates of relapse. It did appear fhat smoking might represent a rIsk
for relapse to substance use (Knisely, Schnoll, & Dawson, 2000). The relationship
between smoking and substance use disorder recovery deserves additional attention in the
future.
Previous studies have examined recovery and relapse issues among physicians
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with substance dependence diagnoses. The Illinois Study involved 278 health
professionals (101 physicians) who successfully completed a residential treatment
program at Rush BehavIoral Health, and entered into an aftercare contract that caned for
monitoring of recovery activities. Favorable outcome in this study was defined as
continuous, uninterrupted abstinence from mood altering, addictive chemicals, and
involvement in all recommended aftercare activities. Relapse was defined as resumption
of the use of mood-altering drugs or alcohol following a (an abstinence) recovery process
(Angres, Talbott, & Bettinardi-Angres, 1998). Because physician impairment programs
in the United States are, for the most part, abstinence recovery model programs, relapse is
defined here as the return to active chemical use, outside of documented prescription as
part of medical care, following a period of abstinence recovery. Models of relapse
conceptualize the phenomenon as a transitional process, a series of events that unfold
over time, with relapse beginning prior to the first post-recovery chemical use and
continuing after the initial use (Larimer, Palmer, & Marlatt, 1999). Much ofthe available
research deals with severely dependent patients who are, because ofthe severe level of
dependence, not appropriate for a goal of moderation; therefore, much of the literature on
relapse deals with abstinence models.
The use of self-help programs, including 12-step programs such as Alcoholics
Anonymous (AA) and Narcotics Anonymous (NA) have also been the subject of some
attention. Project Match compared three psychosocial treatments: Cognitive Behavioral
Therapy (CBT); Motivational Enhancement Therapy (MET); and Twelve-Step
Facilitation Therapy (TSF). In this study, the TSF condition was not so much a therapy
intervention as an aid to facilitate the client's use of 12-step selfhelp programs. The
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counselor met with the client to discuss progress in accessing and utilizing self-help
meetings and concepts. Results from project match showed that 24% ofthe TSF patients
were abstinent throughout months 4-15; 15% of the CBT patients and 14% of the MET
patients were abstinent throughout the period. This advantage for TSF endured
throughout the 12 months of follow-up (NlAAA, 1988). The difference was not reported
as statistically significant by the authors, but it is clear, that for a certain portion of the
client population who are severely dependent and who choose to seek abstinence, the
support offered by 12-step programs can be quite helpful.
The value of 12-step involvement was also demonstrated in a study of cocaine
dependent veterans, in which a number of factors were evaluated in terms of the
relationship of the variables to continued abstinence. Motivation, coping and mood,
social support, co-morbid problem severity, treatment attendance, self-help participation
and cocaine use variables were assessed at each follow up at 6-month intervals over a
two-year period. Only continued self-help participation and early achievement of cocaine
abstinence were seen as significant factors in the maintenance of good outcomes over
extended periods (McKay, Merikle, Mulvaney, Weiss, & Koppenhaver, 2001). There is
evidence in the literature to support the notion that self-help involvement can be a helpful
adjunct to treatment protocols, and that continued participation in self-help programs
reduces relapse.
Maintaining abstinence involves a variety of activities. In one study, authors
interviewed patients over a 30-month post treatment period. They found that a 30 day or
longer period of abstinence were associated with the use of "active strategies". These
included listing the benefits of sobriety, recalling problems associated with drinking, and
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keeping sobriety as a ftrst priority (McKay JR, Maisto SA, & O'Farrell, 1996). Barrick
&Connors, et al. (2002) reported that the most commonly reported methods for
maintaining abstinence were avoiding 'risky' people and places, recalling drinkingrelated problems, and attending self-help groups such as AA (Barrick & Connors, 2002).
To reduce continued substance use most effectively, treatment interventions
should focus on multiple variables, because no single variable strongly predicts continued
use and thus changes on several variables may be required (Brewer & Catalano, 1998). It
will also be important to continue to develop methods of helping those who treat patients
to identifY the relapse factors for the particular client and to help himlher utilize strategies
to cope effectively with those risk factors.
It is clear that there is no one factor that predicts relapse consistently. Itbecomes
increasingly important to identifY mediating factors on an individual basis and to look for
similar patterns in groups of clients so that treatment protocols can address these risk
factors. This study will explore factors in relapse to chemical use among physicians in
recovery from substance dependence.

Factors in Relapse 36
Methods

Subjects
There are 308 subjects in the data set from the original study. These subjects
were broken into two groups, relapse vs. no relapse at 5 years after participation in
the original study, the post-marketing survey on tramadol (Killsely J, Campbell E,
Dawson K, Schnoll S, 2002).

Two subject pools were created by the use of

extensive chart review, during which records were reviewed in detail to determine the
presence or absence of a documented relapse, relapse dates, and diagnoses. Subjects
who participated in at least five years of monitoring post study were eligible for
inclusion into the subject pool. Subjects who had not been followed for at least five
years post original study were excluded from the subject pools. One pool contains
subjects with a documented relapse at 5 years post study, and the other pool contains
subjects without a documented relapse. Careful chart review was utilized to determine
presence or absence of a documented relapse.
For the purpose of the present study, "relapse" is defined as including relapse
behavior along with drug use at a level exceeding episodic or limited use, with
reduced or little program contact. This definition was selected because this pattern
most closely fit the pattern of relapse commonly observed in the monitoring program.
To have selected a level of relapse with a more severe set of characteristics as a
relapse definition would have excluded too great a number of significant relapse
events.
To create the relapse group for this study, 50 subjects were randomly selected
from the relapse pool. Frequencies were determined, and subjects from the non-
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relapse pool were separated by match characteristics, and were randomly selected
from the subset pools to match the 50 relapse subjects, forming the non-relapse
group. Gender was matched first; following this a specialty category was matched.
Specialty categories were defined as: Primary Care, Surgical Specialties,
Anesthesiology, Psychiatry, and Diagnostics. Subjects were matched with a same
gender subject from the same specialty category. All relapse subjects were matched
with a control subject who had participated in monitoring through the date when the
matched subject's relapse occurred. This ensured the same opportunity for relapse for
both case and control during monitoring.
Procedures

Ten dependent variables were extracted from initial interview data collected
during the previous study, and from chart review:
a. age at first use of drug of choice, as reported by the subject during the
intake interview.
b. treatment level received, which was identified as a nominal variable, with
responses indicating the number of experiences in each level of
treatment, including oupatient, intensive outpatient and
inpatient/residential.
c. co morbid psychiatric diagnoses, which were identified as a nominal
variable utilizing the DSM IV classification. Comorbid psychiatric
diagnoses were coded only if assigned by aboard certified psychiatrist.
A listing oftraits, features or a rule out diagnosis was coded as no
diagnosis.
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d. Drug of choice was identified as a nominal variable
e. Smoking history was coded to indicate current, past or never.
f.

Abuse in childhood was coded according to the paliicipant's yes or no
response on the original structured intake interview. (The interviewer
asked if the individual had a history of emotional, physical, or sexual
abuse in childhood or adolescence.)

g. Living arrangement was coded according to whether the individual lived
with a spouse/significant other as opposed to in another living
arrangement.
h. History of substance dependence in family of origin was coded according
to whether or not such a history was reported in answer to a question
posed during the intake interview: ''Does (or did) anyone in your family
of origin have a chemical dependency problem, including mother, father,
sister, brother, paternal grandparents, maternal grandparents, or other.
"Yes", "No", "NA" or "unknown" was recorded for each family member
value.

i.

Other compulsive behaviors reported at time of intake were identified as
a nominal variable. This report was made in response to a question in the
intake interview requesting a yes or no response to "gambling",
"spending", "over-exercising", "sexual behavior", or "other".

j.

Eating patterns/disorder symptoms were coded by responses in the initial
intake interview, acknowledging consistent overeating; purging;
bingeing; and/or tasting/restricting.
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Tune to relapse was measured from data taken from archival records indicating time
from the individual's entry into abstinence recovery and the documented relapse.

Data Ana7ysis
These variables were coded to afford comparison across groups. The independent
variable is relapse. The author compared values on the dependent variables (listed
above) of those who relapsed with those who did not. Continuous variables were
analyzed using a one~way analysis of variance. Nomimal variables were tested using
chi-square tests. Differences in the dependent case control variables between the
relapse and no relapse groups were identified, with alpha set at (p)<.05. Any effect
on relapse status observed as being related to these dependent variables was
considered to be indicative that the variable was associated with a greater risk of
relapse.

Hypotheses
Physicians in recovery from a substance dependence disorder who:
1. have comorbid axis I or axis II psychiatric disorder will be more likely to relapse to
substance use;
2. have received less intensive outpatient treatment will be more likely to relapse than
those receiving more time in residential or inpatient treatment;
3. have overall greater length of use since time of onset of drug use will be more
likely to relapse than physicians with shorter length of use;
4. report narcotics or opioids as a primary drug of choice will be more likely to
relapse than those reporting other primary drugs of choice;
5. smoke tobacco will be more likely to relapse than those who do not smoke;
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6. have a history of emotional, physical, or sexual abuse in childhood will be more
likely to relapse than those without such a history;
7. live with a spouse or significant other will be less likely to relapse than those with
other living arrangements;
8. have a history of substance abuse disorders in their families will be more likely to
relapse than those without such a family history;
9. at the time of intake, reported other compulsive behaviors, which involve
gambling, food, sex, etc. will be more likely to relapse than those who do not report
such compulsive behaviors;
10. report the presence or history of eating disorder symptoms at the time of intake

will be more likely to relapse than those without eating disorder symptoms.
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Results
This data was collected between 1995 and 1998 from a cohort of308 physicians
by telephonic structured interview. Subjects in relapse and non-relapse groups were
matched for gender and for specialty category. The specialty categories used for match
purposes were Primary Care, Surgical Specialties, Anesthesia, Psychiatry, and Diagnostic
Specialties. The demographics offhe sample are shown below:
Table i
Summary of Medical Specialty Categories

Specialty

f

%

Primary Care

56

56%

Surgical

22

22%

Anesthesia

6

6%

Psychiatry

4

4%

Diagnostic

5

5%

Table ii
Gender
Gender

f

%

Male

84

84%

Female

16

16%
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Table iii
Age Range at Recovery

Age Range

Relapse
f
%

Non-Relapse
f
%

20-29

4

8%

2

4%

30-39

24

48%

24

48%

40-49

18

36%

18

36%

50-59

4

8%

6

12%

The outcome information for this sample of physicians shows fhat of the 308 physicians
in the cohort during the previous study, 78 (25%) experienced a documented relapse to
substance use. Of these 78 physicians, 55 were re-engagedinrecovery and continued to
maintain recovery in a documented monitoring program. Time to first relapse is shown
in table iv, and the percentage of subjects with mUltiple relapses is shown in table v.

Table iv
Time to First Rela12se
Year of relapse

f

%

1

10

22%

2-5

24

48%

5-10

10

20%

>10

4

8%
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Table v
Multiple Relapse
% of sample

% of relapse group

Relapse #

f

Second Relapse

26

26%

52%

Third Relapse

16

16%

32%

Hypothesis # 1 : Physicians with co-occurring psychiatric diagnoses will be found more
likely to relapse to substance use.
A 2 X 2 chi-square analysis was performed investigating the effects of co-occurring axis
11 disorders on relapse. The Ss were classified as having had a documented relapse or
having none, and as having a documented axis 11 disorder diagnosis, or having none.
The presence of an axis 11 disorder was strongly related to relapse (X']. = 16.071, df= 1,
p<.05) (Forty-eight percent of the relapse group had an axis 11 diagnosis, compared to
eight percent of the non-relapse group). Comorbid personality disorder diagnoses are
shown in table vi.
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Table vi
Personality Disorder Diagnosis
Personality Disorder f

%

cum%

f

%

cum%

OCPD

4

8%

8%

0

0%

0%

Narcissistic PD

2

4%

12%

0

0%

0%

Borderline PD

2

4%

16%

0

0%

0%

PDNOS

15

30%

46%

4

8%

8%

The effects of co~occurring axis 1 disorders were also analyzed.

A 2 X 2 chi-square analysis was performed investigating the effects of co-occurring (nonsubstance related) axis 1 disorder on the outcome of relapse. Ss were classified as having
a documented relapse or not, and as having a comorbid axis 1 (non-substance) diagnosis,
or having none. The presence of a comorbid axis 1 diagnosis was significantly related to
relapse (X" = 9.180,

1, p<.05).

The incidence of comorbid (non-substance related) axis I diagnosis is summarized in
table vii.

When the presence of an axis II disorder is combined with the presence of a secondary
axis I disorder (not including secondary substance use disorder diagnoses), the presence
of a co-occurring psychiatric disorder on axis I or axis II was strongly related to relapse

(x" = 23.645, df

,p<.05).

The percentages of subjects with a comorbid axis 1 or axis II diagnosis are summarized in
table viii.
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Table vii
Comorbid Axis I Diagnoses
cum%

%
f
non-relapse

cum%

% cum%
total sample

12%

12%

1

2%

2%

7%

12

24%

36%

7

14%

16%

19% 26%

Dysthymic

1

2%

38%

2

4%

20%

3%

29%

Bulimia

3

6%

44%

3

6%

26%

6%

35%

PTSD

1

2%

46%

1

2%

28%

2% 37%

AnxietylPanic

3

6%

52%

0

0%

28%

3% 40%

OCD

1

2%

54%

0

0%

28%

1% 41%

Sexual

1

2%

56%

0

0%

28%

1% 42%

ADHD

1

2%

58%

0

0%

28%

1% 43%

Axis I disorder

f

Bipolar

6

Major Depressive

%
relapse

7%

Table viii
Comorbid disorder (Axis I or II)
Relapse Status

f

% of relapse group

Relapse

41

82%

No Relapse

17

34%

Comorbid psychiatric disorder was also analyzed to see lithe presence of a
comorbid disorder on Axis lor II would be related to the time to first relapse. A one-way
analysis of variance was performed to test for significance of relationship between these

Factors in Relapse 46

Hypothesis # 2: Physicians who receive inpatient or residential treatment are less likely
to relapse to substance use.
A 2 X 2 chi-square analysis was performed investigating the effects ofthe level of
treatment received. Ss were classified as having had at least one residential treatment
experience or having had none as reported at the time ofthe intake interview. There was
no observable effect of inpatient treatment on relapse in this sample ("1.,2

0.98, P > .05).

Treatment modality percentages are summarized in table ix.

Table ix
Summary of Treatment Modality Results
Treatment Modality f
%
f
%
f
%
________________-=re=la~p~s=e ____~n=o=n~-r=e=ill+p=se~~t=o=ta=l~s='am~p=le~
Residential

42

84%

40

80%

82

82%

No Residential

8

16%

9

18%

17

17%

Note: One subject did not answer this question.

Hypothesis #3: Physicians who report a history of a family member with a substance use
disorder (Family SUD History) will be more likely to relapse than those with no such
family history.
A 2 X 2 chi-square analysis was performed investigating the effects of family history on
relapse. Ss were rated according to whether or not they self-reported a family member
with a substance use disorder. Family history of substance use disorder was not related to
relapse (X}

2.312, P>.05). In fact, a slightly greater portion of those reporting a family

history of abuse were non-relapse group subjects. Percentages of subjects reporting a
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family history of substance use disorder are summarized in table x.

Hypothesis # 4: Physicians with a history of abuse in childhood will be more likely to
relapse to substance use.
A 2 X 2 chi-square analysis was performed investigating the effects of a history of
childhood abuse on the outcome of relapse. Three types of abuse, sexual, physical, and
verbal, were collapsed to provide a rating for each S as the presence or absence of a selfreport of one or more of the three abuse types. This measure was not related to relapse

(X2 = .523, p>.05).
History of abuse was also measured against time to relapse to see if an abuse history
would be related to the amount of time between recovery and first relapse. Abuse history
did not predict time to relapse in this sample (F = .014, df= 1, p>.05).
Percentages of subjects reporting a history of abuse are summarized in table x.

Hypothesis # 5: Physicians who report a history of eating disorder symptoms will be
more likely to relapse than physicians without such a history.
Ss were asked at intake to state whether they or not had a history of several different
eating disorder symptoms, including bingeing, purging, overeating, and restricting or
fasting. These data were collapsed to represent the presence or absence of at least one
eating disorder symptom. A 2 X 2 chi-square analysis was performed to investigate the
relationship between eating disorder symptoms and a relapse outcome. There was no
relationship between these variables observed in this sample (X2 = .042, P > .05).
Percentages of subjects reporting a eating disorder symptoms are summarized in table x.
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Hypothesis # 6: Physicians who report a history of compulsive behaviors other than
substance use will have a greater likelihood of relapse than physicians without such a
history. Ss were asked at the time of intake to report whether or not they had a history of
compulsive behaviors, including gambling, eating, sexual behavior, over-exercising,
spending, or other compulsive behavior. These data were collapsed into presence or
absence of a reported compulsive behavior. A 2 X 2 chi-square analysis was performed
to investigate the relationship between histories of compulsive behavior and relapse
outcome. No relationship between these variables was evident in this sample of
physicians (X2 = .1.362, p>.05).
Percentages of subjects reporting other compulsive behaviors are summarized in table x.

Table x
History of Related Conditions/Issues
Condition

f

%
relapse

f
%
non-relapse

Family SUD History 30

61%

37

75%

Abuse History

26

52%

22

45%

Eating Disorder

10

20%

11

21%

ComQulsive Behavior 15

30%

11

21%

Hypothesis #7: Physicians with opiates as the drug of choice will be more likely to
relapse than physicians with other drug preferences. Drug of choice data was collapsed
opioid drug of choice vs. non-opiate. A 2 X 2 chi-square analysis was performed to
investigate the relationship between opioid use and relapse outcome. There was no
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relationship demonstrated in this sample of physicians between opioid use and relapse
outcome (X}

.040, p > .05).

Percentages of physicians reporting opioids as their drug of choice are summarized in
table xi.

Table xi
Opioid as Drug of Choice

%

Drug of Choice

f

Opioid

relapse
23
46%

Non Opioid

27

54%

f

%

non-relapse
22
44%
28

56%

Self-reported use of opioids as a drug of choice was checked against DSM IV-TR
diagnosis code 304.00, to see if assigned diagnosis of opiate dependence would correlate
with relapse. There was no significant relationship in this sample between opiate
dependence diagnosis and relapse (X2 = .770, p>.05).

Hypothesis #8: Physicians with an overall greater length of use since onset of drug use
will be more likely to relapse than physicians with a shorter length of use. Physicians
were asked to provide information about their ages at the time of onset of use oftheir
drug of choice. A one-way analysis of variance was used to test for the strength of
relationship between age at frrst use and outcome of relapse vs. non-relapse. Because age
at first use was distributed evenly across both groups, age at first use did not show a
significant correlation with relapse outcomes (F=.008, df=l, p>.05).
Age at first use was also collapsed into age ranges to see if onset during a particular
period of life would be related to relapse. Age ranges were defined as 0 to 19,20 to 30,
and >30. A 3 X 2 chi-square analysis was performed to investigate the relationship
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between age ranges offirst use and the relapse outcomes. There was no relationship
demonstrated in this sample between age range of first use and relapse outcome
(y} = .132, df= 2, p>.OS).

Age categories at onset of use ofthe drug of choice are summarized in table xii.

Table xii
Age CategOl:Y at Onset Summary
%
relapse

Age at Onset

f

<19 years

17

20-30 years
>30 years

cum%

f
%
non-relapse

cum%

34%

34%

17

34%

34%

20

40%

74%

18

36%

70%

13

26%

100%

14

28%

100%

Hypothesis # 9: Physicians with a history of smoking tobacco will be more likely
to relapse than physicians who have never smoked. Smoking data was collected at the
time of entry into the original study; the subject was asked to respond with past, with
current or with never concerning smoking history. The data were collapsed for this
analysis, into smoking history (including subjects who reported past or current smoking
at the time of intake) or no smoking history (including subjects who reported never
smoking). A 2 X 2 chi-square analysis was performed to investigate the relationship
between smoking history and relapse. There was no observed correlation between
smoking history and relapse in this sample (X2

2.S2, P> .OS). In fact, a greater

proportion ofnon-relapsers (S8%) reported a smoking history than did relapsers (S2%).
Percentages of subjects reporting a smoking history are summarized in table xiii.
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Table xiii
Summary of Smoking History
Smoking History

f

%

f

%

SmokingHx

26

52%

29

58%

No Smoking Hx

21

42%

21

36%

Smoking history was also compared to the time to relapse to see if a history of smoking
tobacco would be related to the amount of time between recovery and first relapse.
Smoking history did not predict the time to relapse in this sample (F = 000, df= 1, p>.05)

Hypothesis # lO: Physicians who live with a significant other will be less likely to relapse
than those who do not.
Data relating to living situations was collapsed to represent living with a spouse or
significant other vs. other living arrangements, including living alone, living with
children or parents, or living with roommates. A 2 X 2 chi-square analysis was
performed to investigate the effects of living arrangements on the outcome of relapse vs.
non-relapse. There was no demonstrated relationship between the variable of living
arrangements and relapses (X2 = .082, df= 1, p> .05).
Subjects reporting living with a spouse or significant other are summarized in table xiv.
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Table xiv
Living Arrangements
Living Arrangements f

%
relapse

f
%
non-relapse

Live with sig.other

37

74%

35

71%

No sig. other

13

26%

14

29%
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Discussion
The outcome data shown in the results seetion indicate that approximately 25% of
the 308-physieian eohort in the study suffered a documented relapse to substance use. It
is interesting to note that this is the same relapse percentage as reported by the
Washington Physician Health Program (Domino, Hombein, Polissar, Renner, Johnson,
Alberti, & Hankes, 2005) when studying data from the same time period on a
Washington State cohort of physicians who were involved in the same data collection
study between 1995 and 1998 (Knisely, Campbell, Dawson, & Schnoll, 2002). It is
important to note that 55 of the 78 physicians who relapsed in the Pennsylvania study
were successfully re-engaged in monitored recovery. This represents a long-term rate of
engagement in recovery of92% over a period of the 10 years since the onset of the initial
study. These findings underscore the value of monitored recovery for physicians and
other professionals. As noted, 28% of these relapses occurred beyond the fifth year of
monitoring, and 8% occurred beyond the 10th year (see table iv). The incidenee of relapse
beyond the fifth year of monitored recovery demonstrates the need for long term
monitoring.
The variable showing the strongest relationship to relapse is the presence of a cooceurring psychiatric disorder. When the presence of an axis II disorder is crosstabulated with relapse, 48% of the relapse group has a documented axis II diagnosis
compared to only 8% of the non-relapse group. When co-occurring axis I diagnoses are
added (with secondary substance use disorder diagnoses not counted), 74% of the relapse
group had a co-occurring psychiatric diagnosis, compared to 26% of the non-relapse
group. No subjects with only a notation of "traits" or "features" of personality disorders
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were included in the axis II diagnosis data. Only cases in which a diagnosis had been
made by a board-certified psychiatrist were coded as such. Still, the presence of an axis
II disorder or a co-occurring axis I psychiatric disorder was significantly related to
relapse. However, the presence of a co-occurring psychiatric disorder did not predict the
time to relapse in this sample.
A residential or inpatient treatment experience was hypothesized to make relapse
less likely than an outpatient treatment experience. This sample did not demonstrate a
relationship between the levels of treatment received and relapse. However, the data
must be viewed in the context ofthis particular sample. 82% of the sample, including
both relapse and non-relapse groups reported having received a residential or inpatient
treatment experience at the time of intake. The high percentage of subjects received
residential treatment the dominant treatment model in addiction medicine. The data
available from this cohort do not appear to be mixed enough to test this hypothesis
adequately.
There is much information in the literature suggesting that a family history of
substance abuse appears to make a substance use disorder more likely (Hasselbrock,
1995). This data set supports the presence of such a relationship between family history
and substance abuse. In this sample, 61 % of the subjects in the relapse group, and 75%
of those in the non-relapse group reported a family history of substance abuse. Clearly,
the data from this sample of recovering physicians seem to support the conclusion that a
family history of substance use disorder may be a risk factor in the development of such a
disorder. However, within this cohort of recovering addicted physicians, there was no
significant difference in risk for relapse between those reporting a family history of
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substance use disorder and those reporting no (known) family history of such a disorder.
The data from the Washington study indicate that the presence of a family history is
strongly related to relapse. In fact, in that sample, the presence of a family history
doubled the risk of relapse (Domino, Hornbein, Pollisar, Renner, Ginger, Johnson,
Alberti, & Hankes, 2005).
Subjects reporting a history of abuse (physical, verbal or sexual abuse during their
childhood) were evenly distributed across both groups. The percentage of the overall
sample, comprising both case and control groups report a substantial history of abuse.
Nearly half of the entire sample reported a history of abuse, with 45% of the non-relapse
group reporting an abuse history compared to 52% of the relapse group. A significant
risk for relapse was not noted. When the history of eating disorder symptoms is
examined, 20% of the overall cohort reported a history of eating disorder symptoms.
Subjects reporting eating disorder symptoms were evenly distributed across the case and
control groups (21 % of non-relapse vs. 20% of relapse). There is no significant
difference between the case and control groups on this variable, and no observable effect
of eating disorder symptoms on the relapse outcomes. These data may have been
underreported, suggesting that it will be important in the future to collect such data in a
manner that might enhance accuracy, increasing the probability that such disclosure
would be made.
A history of other compulsive behaviors has been shown to be related to
substance use disorders (Kausch, 2003; Schmitz, 2005; Ladd & Petry, 2003). In this
sample, across both case and control groups, nearly 26 % ofthe total number of
participants reported a history of other compulsive behaviors. The difference between
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case and control, however, was not significant. Approximately 30% ofthe relapse group
compared with 21 % of the non-relapse group reported other compulsive behaviors.
In the study carried out by the Washington State Physician Health Program, use of

narcotics appeared as a risk factor for relapse, but only when combined with a comorbid
psychiatric disorder. (Domino, Hornbein, Polissar, Renner, Johnson, Alberti, & Hankes,
2005). In a study published by researchers at Rush Behavioral Health, it was noted that
psychiatric comorbidity was more likely in the opiate (as drug of choice) category than in
other categories, suggesting that this relationship between comorbid diagnosis, relapse,
and choice of opiates is complex (Angres, McGovern, Rawal, Purva, & Shaw, 2002). In
the present study cohort, the self-reported drug of choice as opiates was evenly
distributed across both groups (46% both for relapse and non-relapse). This variable was
cross-checked by reviewing diagnoses assigned by treatment professionals. When the
diagnosis of opiate dependence, DSMIV TR code 304.00, is tracked in this sample, there
are more relapse subjects (46%) carrying this diagnosis than non-relapse subjects (38%).
The difference does not, however, approach statistical significance (X2

.770, p>.05).

Length of use is a variable that appears in the literature to be related to risk of
relapse. In this sample, age at first use as reported by the subject at intake was recorded
as the age offirst use of the drug of choice. Therefore, for physicians who entered
treatment because of narcotic addiction, early onset of alcohol and drug abuse of
substances other than narcotics would not appear as a factor. A more careful interview
technique, gathering information approximating the onset of drug/alcohol abnse in
general, rather than age of onset of use of the drug of choice at intervention, may provide
a more meaningful comparison. Such a method of gathering data would reveal, for
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example, if a physician who began to abuse alcohol and marijuana as an adolescent, but
began to use opiates only several years prior to intervention, he or she is more at risk for
relapse than a counterpart who began using opiates at approximately the same time but
had no history of polysubstance abuse. On the basis of the self-reported age offrrst use
ofthe drug of choice at the time of intake, there was no significant difference in age at
frrst use between the case and control groups.
Smoking history was shown to be a factor related to relapse in the 4-state cohort
studied by Knisely et al in the Tramadol post-marketing study (Knisely, Campbell,
Dawson, & Schnoll ,2002). In this sample, relapsers were only slightly more likely
(59%) than non-relapsers (55%) to have reported a history of smoking. When only
current smoking was reported, the percentages shift to 26% of relapsers reporting current
smoking, compared to 41 % ofnon-relapsers. This difference does not reach the level of
statistical significance and cannot quite be called a trend, but it is an interesting
characteristic of the cohort. There was no significant relationship observed between
smoking and relapse in this sample.
Living situations are commonly held to be important factors in recovery from
substance use disorders. The living arrangements ofthe patient are factored into the level
of treatment placement criteria of the American Society of Addiction Medicine as an
important aspect in differentiating intensity of care needed (ASAM, 2001). At the time
of intake interview, subjects in this sample were asked about their living arrangements.
Those responses were reviewed for this study, and the data collapsed to show the variable
of living with a spouse/significant other or living in another type of arrangement such as
living alone, living with children, etc. The results indicate no observable relationship
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between this variable and relapse; 74% of the relapse group reporting living with a
significant other, compared to 71 % of the non-relapse group.
In addition to the results, there are several limitations in this study that should be
considered. This research was carried out using archival data that was gathered for a
previous study. This retrospective study evaluated responses given by subjects to
questions asked of them upon their entering the previous study. Subjects with a known
documented relapse are compared to subjects without a documented relapse. The
subjects' responses which were given 7 to 10 years prior provide much of the data
concerning the variables explored in this study.
The data represent the subjects' responses to questions contained in a structured
interview, and are thus self-reported data. Because these responses are self-reported,
internal validity is threatened to the extent that data may not have been reported
accurately. There are potential differences in the ways in which people self-report data
such as these, and these differences could affect the results of the data analyses.
Because information about factors regarding personal history is very sensitive, physicians
may not have been comfortable disclosing such information in this structured interview
format, especially because these data were gathered by telephone. Data on family history
of substance abuse or dependence, eating disorder symptoms, history of abuse, and other
compulsive behaviors might be more accessible if it is gathered in person.
A second threat to internal validity in this study is the chance of diagnosis being
assigned to a given subject. A subject who relapses and reenters a treatment program has
a greater likelihood of receiving a comorbid psychiatric diagnosis than his or her
counterpart in the non-relapse group. With respect to Axis II disorder diagnoses, because
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these disorders are durable, long-term conditions, the assignment ofthe diagnosis at any
time implies that the diagnosis has been present for a long time. The presence of an Axis
II diagnosis was included whether assigned at a first or a second treatment experience.
Axis I disorders were handled in a similar fashion. If an Axis I comorbid psychiatric
disorder was diagnosed just after a relapse occurred, there is great likelihood that the
condition affected the relapse. Rather than losing this data, diagnoses were collected
from both initial and subsequent treatment experiences. But the choice to include this
data can also be seen to expose the relapse group to greater chance of diagnosis because
of an additional exposure to an evaluation process.
A second threat to internal validity of this the lack of randomness which is
inherent in a case control design. There may be other factors affecting relapse that were
not accounted for in the design. This study was designed to control for some potential
differences by matching relapse and non relapse physicians by gender and specialty type.
A third limitation ofthis study is that its design limits the use to which the data
analyses can be put. Because it is a retrospective case control design looking back from a
point of known outcome and comparing variables between the groups, causality cannot
be inferred. The variables were not controlled in an experimental way. Instead, the study
evaluates the strength of relationship between certain variables and the outcome of
relapse, as well as the relationship between some of the variables. One cannot draw
conclusions of causality from these data analyses. One can, however, measure the
relationships between variables and known outcomes and the strength ofthose
relationships within the sample.
The use of matched control groups strengthened the current study design.
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Because relapse and non-relapse subjects were matched according to gender and
specialty type, internal validity was strengthened. Other variables for matching might be
identified in the future.

Recommendations
Additional research should be considered in the future to review some of the
variables that did not show significance here, particularly family history of substance use
disorder, history of abuse, and history of eating disorder symptoms, and other compulsive
behaviors. It is possible that a more personalized data collection method would
encourage accurate reporting of such data.
Virtually all of the subjects in the study approached recovery through a 12-step
abstinence recovery model. Because the recovery rate, including those who experienced
relapse but successfully re-entered recovery, is high (approximately 92%), it is clear that
this recovery model is indeed effective. The findings on co-occurring disorders, which
include primary psychiatric disorders such as bi-polar disorder and Axis II or personality
disorders, appear to present barriers to physicians in utilizing their 12-step recovery tools
and support systems; this makes those physicians more prone to relapse. These findings,
along with data from the Washington State PHP study, indicate that more attention is
needed to co-occurring disorders in physicians who experience more difficulty in using
Alcoholics Anonymous, Narcotics Anonymous, and similar 12-step programs and
recovery tools effectively. It may be appropriate to encourage these individuals to obtain
help to address co-occurring psychiatric disorders specifically, in order to enhance their
ability to utilize recovery tools.
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Diagnosis of Axis II disorders can be difficult, especially early in recovery.
Treatment providers hesitate to assign a personality disorder diagnosis when early
recovery toxicity or other issues might be affecting the patient. Axis I disorders are more
visible and more readily diagnosed. In addition, the assignment of a comorbid psychiatric
diagnosis can divert the patients' attention from their need to address their substance
dependence disorders, which in turn could hamper the patients' ability to recover, rather
than enhance their possibility of recovery.
Data from studies conducted at Rush Behavioral suggest several important points
with regard to physicians in treatment for substance use disorders, who also have
comorbid psychiatric disorders:
1.

They have a different course of treatment experience; they seem
to need to make more appreciable gains to reach comparable
status with their counterparts, and may stay in treatment longer
to make these gains;

2.

They tend to leave treatment having made progress in recovery
that is comparable to their counterparts;

3.

They seem to have similar substance abuse outcomes at follow
up, but report higher levels of emotional distress than their
counterparts.

The average follow up period in this study was 2.5 years. These results suggest that
physicians with comorbid psychiatric disorders get as much or more out of treatment than
their counterparts, and are able to utilize recovery tools effectively. These results,
together with the data from the current study, suggest that an important time period for
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concern about the physician in recovery from a substance dependence disorder with a
comorbid psychiatric disorder may be beyond the two to three year point. It may be that
such physicians are able to utilize AA, NA and other 12-step programs effectively, and
utilize recovery skills learned in treatment, but could have difficulty over the longer term
in continuing to use these strategies effectively, in part complicated by their comorbid
disorder.
Given these issues, it appears to be important for professional peer-assistance and
monitoring programs to attempt to collect information concerning comorbid disorders,
using this information to inform long-term aftercare and outpatient treatment planning
and monitoring arrangements. Aftercare therapists could be made aware ofthese issues,
and monitoring arrangements could be set up to afford adequate attention to treatment of
comorbid disorders. It is important to safeguard the patient's confidentiality in this
process. It would be potentially valuable to gather qualitative or case study infonnation
in order to view this issue from the point of view of the recovering participant. This
information may provide more direction on future experimental inquiries, as well as on
program improvement efforts.
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